Eribulin Mesylate .5 mg/mL (Eribulin Mesylate INJECTION) .5 mg/mL

Eribulin Mesylate .5 mg/mL is an injectable medication used for specific cancer treatments. This intravenous solution is manufactured by Sandoz Inc in the USA, providing a reliable option for medical professionals.

Strength

.5 mg/mL

Pack Size

1 VIAL in 1 CARTON (0781-3391-94) / 2 mL in 1 VIAL

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eribulin Mesylate is primarily used in the treatment of certain types of cancer. It is administered intravenously and is often prescribed for conditions where other treatments may not be effective. The medication works by targeting cancer cells to slow their growth and spread. Patients and healthcare providers should discuss the specific uses of Eribulin Mesylate to determine if it is suitable for their needs.

Side Effects

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some patients may also experience changes in blood cell counts or peripheral neuropathy. These effects can vary widely among individuals, and it is important to monitor for any adverse reactions. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Eribulin Mesylate should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should be monitored regularly for any signs of adverse effects. Pregnant women or those planning to become pregnant should discuss the risks with their healthcare provider.

Avoid Interactions

Eribulin Mesylate may interact with other medications, including those that affect the liver or bone marrow. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Eribulin Mesylate, so it is advisable to discuss these with a medical professional.

Frequently Asked Questions

Eribulin Mesylate is used in the treatment of certain types of cancer, often when other treatments have not been effective.

Eribulin Mesylate is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, hair loss, and changes in blood cell counts.

It is important to discuss all medications with your healthcare provider to avoid potential interactions.

Pregnant women should discuss the risks and benefits with their healthcare provider before using Eribulin Mesylate.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.